LLY

1,017.74

+3%↑

JNJ

194.37

+0.29%↑

ABBV

233.26

+3.63%↑

UNH

339.07

+3.56%↑

AZN

87.67

-1.55%↓

LLY

1,017.74

+3%↑

JNJ

194.37

+0.29%↑

ABBV

233.26

+3.63%↑

UNH

339.07

+3.56%↑

AZN

87.67

-1.55%↓

LLY

1,017.74

+3%↑

JNJ

194.37

+0.29%↑

ABBV

233.26

+3.63%↑

UNH

339.07

+3.56%↑

AZN

87.67

-1.55%↓

LLY

1,017.74

+3%↑

JNJ

194.37

+0.29%↑

ABBV

233.26

+3.63%↑

UNH

339.07

+3.56%↑

AZN

87.67

-1.55%↓

LLY

1,017.74

+3%↑

JNJ

194.37

+0.29%↑

ABBV

233.26

+3.63%↑

UNH

339.07

+3.56%↑

AZN

87.67

-1.55%↓

Search

Medpace Holdings Inc

Suletud

SektorTervishoid

595.74 -0.48

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

595.74

Max

607.82

Põhinäitajad

By Trading Economics

Sissetulek

21M

111M

Müük

57M

660M

P/E

Sektori keskmine

42.018

105.69

Kasumimarginaal

16.841

Töötajad

6,200

EBITDA

32M

150M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

-12.92% downside

Turustatistika

By TradingEconomics

Turukapital

1.6B

17B

Eelmine avamishind

596.22

Eelmine sulgemishind

595.74

Uudiste sentiment

By Acuity

50%

50%

182 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

Medpace Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. okt 2025, 15:15 UTC

Tulu

Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Medpace Holdings Inc Prognoos

Hinnasiht

By TipRanks

-12.92% langus

12 kuu keskmine prognoos

Keskmine 524.89 USD  -12.92%

Kõrge 655 USD

Madal 425 USD

Põhineb 10 Wall Streeti analüütiku instrumendi Medpace Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

10 ratings

1

Osta

7

Hoia

2

Müü

Tehniline skoor

By Trading Central

300 / 302.88Toetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Sentiment

By Acuity

182 / 374 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
help-icon Live chat